During an 8.5-month period, 198 additional isolates of Serratia marcescens were typed by bacteriocin sensitivity; 154 isolates were typable and were categorized according to our current system of 54 provisional bacteriocin sensitivity patterns. Two outbreaks of nosocomial infection due to S. marcescens occurred in our intensive care unit, involving two and five patients, respectively. The latter outbreak was caused by a strain of S. marcescens which was not sensitive to any of the 10 bacteriocins normally used. Therefore we developed a supplementary procedure based on bacteriocin production rather than bacteriocin sensitivity. Bacteriocin production was induced with mitomycin C, and the crude lysates were applied to 15 provisional bacteriocin indicator strains. The reverse typing procedure was necessary to determine the spread and ultimate subsidence of this particular outbreak of cross-infection.
Recently we developed a simple procedure for typing clinical isolates of Serratia marcescens by bacteriocin sensitivity (7) . The application to the study of hospital-acquired infections was presented in a subsequent communication (6) . Here we wish to present further data. The previous scheme of 37 bacteriocin sensitivity patterns now has been expanded to 54, based on the results obtained from 198 additional clinical isolates. A strain of S. marcescens that had acquired nosocomial significance in our intensive care unit was found to be resistant to all 10 bacteriocins employed in our standard procedure. Therefore, a supplementary reverse typing procedure was developed.
MATERIALS AND METHODS
From 16 April through 31 December 1971, 198 isolates of S. marcescens were recovered from clinical specimens derived from 144 patients and the hospital environment. The isolates were identified and typed by bacteriocin sensitivity as previously described (5-7). Those isolates from patients in the intensive care unit which were resistant to all 10 of ' Table  2 . The majority of the isolates were of bacteriocin types 1, 4, 9, 14, 16, 18, and 21, as noted previously (6) . A total of 44 isolates of the current series proved nontypable. Thirteen of these latter isolates (plus 6 of 12 isolates, designated S-ICC 1 through S-ICC 12) were recovered from patients in our intensive care unit during the period of October through December 1971. The bacteriocin production pattern (host range) of all isolates comprising this strain is listed in Table 3 . Relevant epidemiological data concerning this strain were presented in Table 4 .
Patient C.V.G., the probable index case, was admitted to North Carolina Baptist Hospital on 10 October 1971. Surgery was performed 10 days later. Before his transfer to the intensive care unit on 20 October 1971 this patient had been hospitalized in room no. 357. Subse- (Table 4) .
On 30 November two more patients with infection due to S. marcescens were discovered. Patient J.L.H. (resection of aortic aneurysm) had acquired postsurgical wound infection due to S. marcescens of bacteriocin type 7. Patient C.B.R. (chronic alcoholism, hepatic coma) yielded S. marcescens of bacteriocin type 1 from sputum, tracheal aspirate, and rectal swab specimens prior to her death on 8 December. However, these latter two strains of S. marcescens did not acquire nosocomial significance. Thus, on 30 November 1971 there were four strains of S. marcescens prevalent in the intensive care unit, as judged by their different sensitivities to bactieriocins.
The data obtained with bacteriocin typing of 198 additional clinical isolates of S. marcescens allowed us to expand the system of categorization according to bacteriocin sensitivity from the previous 37 to the present 54 provisional bacteriocin types. The large number of nontypable isolates encountered during the current observation period was partly attributable to the emergence of a nontypable strain of S. marcescens that gained nosocomial significance. It may be added that S. marcescens isolate no. 326 (from patient C.V.G.) proved serologically nontypable (Betty Davis, Center for Disease Control, Atlanta, Ga., personal communication). If one were to examine all nontypable clinical isolates of S. marcescens with the supplementary reverse typing procedure, one might possibly be able to type roughly 75% of these isolates as based on the extent and specificity of host ranges of elaborated bacteriocins against selected indicator organisms. Previously we had found that roughly 75% of 50 isolates of S. marcescens proved bacteriocinogenic (7) .
As noted previously, no major hospital-wide outbreaks of cross-infection due to S. marcescens were discernible during the present observation period. The value of the bacteriocin typing procedure was underscored by the finding that on 30 November 1971 there were four strains of S. marcescens prevalent among patients of our intensive care unit. Of these, two strains were shown to be nosocomially significant. One strain (bacteriocin type 14) spread from one patient with serious infection following open-heart surgery to the respiratory tract of another patient. The other outbreak of cross-infection involved five patients, two of whom had significant infection. The organism appeared to contribute toward mortality in one patient (C.V.G.), the probable index case. There were a number of disturbing findings in this outbreak. First, hand transmission of the outbreak was very likely since one of the maids of the intensive care unit carried this strain on her fingertips (3). Second, the strain was recovered from serveral inanimate sources. Thus, this strain had become established in a number of inanimate reservoirs, in contrast to findings on Klebsiella pneumoniae strains in an intensive care unit (4) . Third, the finding that the outbreak strain had been transmitted to a patient who had been on protective isolation in the intensive care unit ever since his admission to the hospital indicated a breakdown of the technique of reverse isolation. These findings resulted in extensive and rigorously enforced combative prophylactic and educational measures, including strict isolation of every patient with known S. marcescens infection, which limited and ultimately brought under control this outbreak of crossinfection.
